Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of GBP 11.40 billion. The enterprise value is 11.15 billion.

Market Cap	11.40B
Enterprise Value	11.15B

Important Dates

The next estimated earnings date is Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+13.14%
Shares Change (QoQ)	+12.29%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	166.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	48.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-17.28
EV / Sales	40.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.49

Financial Position

The company has a current ratio of 6.37, with a Debt / Equity ratio of 2.40.

Current Ratio	6.37
Quick Ratio	5.83
Debt / Equity	2.40
Debt / EBITDA	n/a
Debt / FCF	-1.82
Interest Coverage	-8.45

Financial Efficiency

Return on equity (ROE) is -890.75% and return on invested capital (ROIC) is -32.53%.

Return on Equity (ROE)	-890.75%
Return on Assets (ROA)	-26.05%
Return on Capital (ROIC)	-32.53%
Revenue Per Employee	280,571
Profits Per Employee	-707,065
Employee Count	912
Asset Turnover	0.20
Inventory Turnover	0.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +174.43% in the last 52 weeks. The beta is 1.12, so Insmed's price volatility has been higher than the market average.

Beta (5Y)	1.12
52-Week Price Change	+174.43%
50-Day Moving Average	71.55
200-Day Moving Average	62.59
Relative Strength Index (RSI)	64.69
Average Volume (20 Days)	1,038

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.88

Income Statement

In the last 12 months, Insmed had revenue of GBP 255.88 million and -644.84 million in losses. Loss per share was -4.15.

Revenue	255.88M
Gross Profit	197.66M
Operating Income	-525.20M
Pretax Income	-642.28M
Net Income	-644.84M
EBITDA	-518.58M
EBIT	-525.20M
Loss Per Share	-4.15

Full Income Statement

Balance Sheet

The company has 1.10 billion in cash and 865.41 million in debt, giving a net cash position of 229.79 million.

Cash & Cash Equivalents	1.10B
Total Debt	865.41M
Net Cash	229.79M
Net Cash Per Share	n/a
Equity (Book Value)	360.68M
Book Value Per Share	2.02
Working Capital	1.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -461.63 million and capital expenditures -12.91 million, giving a free cash flow of -474.54 million.

Operating Cash Flow	-461.63M
Capital Expenditures	-12.91M
Free Cash Flow	-474.54M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.25%, with operating and profit margins of -205.25% and -252.01%.

Gross Margin	77.25%
Operating Margin	-205.25%
Pretax Margin	-251.01%
Profit Margin	-252.01%
EBITDA Margin	-202.67%
EBIT Margin	-205.25%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.14%
Shareholder Yield	-13.14%
Earnings Yield	-5.66%
FCF Yield	-4.16%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Insmed has an Altman Z-Score of -0.45. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.45
Piotroski F-Score	n/a